via Kagan Institute
Breakthrough by experts supports drug therapy as alternative to surgery
World-leading eye experts have made a breakthrough that could potentially change the way cataracts are treated – with potential for drug therapy to replace surgery.
Cataract is a clouding of the eye lens that develops over time and affects the quality of vision. It is caused by an accumulation of protein in the lens that reduce the transmission of light to the retina. Previous research led by ARU found that cataracts account for almost half of global cases of blindness.
A significantly developed cataract can only currently be treated by a surgical procedure to remove the cloudy lens and insert an artificial replacement.
A team of international scientists, led by Professor Barbara Pierscionek of Anglia Ruskin University (ARU), has published peer-reviewed research that shows the sophisticated optics of the lens develops much earlier in gestation than has previously been thought possible. They also found how a particular protein (aquaporin) responsible for water passage in the lens disrupts the optical development, leading to cataract formation.
The scientists have spent more than a decade conducting the most precise measurements on optics of the lens at SPring-8, the world’s largest and most powerful synchrotron, in Japan.
The synchrotron is a particle accelerator that produces powerful X-rays by accelerating electrons to the speed of light. The X-rays allow measurements to be taken with the highest accuracy yet on optical properties of the eye.
The project team is the first in the world to have measured how the optics in the eye lens develop. Their research was presented earlier this month at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting.
Professor Pierscionek, Deputy Dean (Research and Innovation) for the Faculty of Health, Education, Medicine and Social Care and member of the Medical Technology Research Centre at ARU, said: “Cataracts are one of the main causes of vision loss and blindness worldwide, yet for many people surgery is inaccessible for various reasons.
“Our findings indicate the role of the aquaporin proteins and the crucial importance of this for the lens to work correctly and the eye to see clearly.
“Further research in this area is planned, but this discovery, together with our research on nanotechnologies that indicate drug therapy for cataract is possible, could potentially revolutionise the way cataract is treated, opening up the field for drug-based therapy rather than surgery. This would have exciting implications for public health.”
Original Article: New research may revolutionise cataract treatment
More from: Anglia Ruskin University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- LensGen® Receives IDE Approval from the U.S. FDA to Begin Clinical Study of the Juvene® Presbyopia-Correcting Intraocular Lens
LensGen, Inc., a privately held ophthalmic medical device company, announced today that it has received approval for an Investigational Device Exemption (IDE) from the U.S. Food and Drug ...
- Patients with cataracts are not disabled, says Dr Atwine
Cataracts can be corrected through surgery whereby the clouded lens is removed and replaced with a clear artificial lens ...
- Global Ophthalmic Lasers Market is Estimated to Grow at a CAGR of 1.6% from 2020 to 2028; Quince Market Insights
Major key market players operating in the global ophthalmic laser market include: Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd, Qauntel Medical, Alcon, Iridex Corportaion, Lumenis, Aurolab ...
- The New Rolex Datejust’s Dial Was Etched Using the Same Lasers That Remove Cataracts
Just as noteworthy, though, is the laser technique used to create the etching, which is the same one used to help remove cataracts. More from Robb Report This Mercedes-Benz X Series Pickup Was ...
- Days of chrome, dents and no cataracts
The Texas sun has a way of giving today’s cars the automotive version of cataracts. It’s easier to fix human eyes. But surprise -- I just bought a ten-year-old car with pristine lenses.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Drug therapy for cataracts
- Zane Andrew Henderson sentenced to nine months in jail for several offences
The Magistrate said the 26-year-old Mayfield man had a responsibility to support his mother in the wake of his teenage brother's tragic death.
- These Healthcare Stocks Should Thrive in 2022
Of course, the healthcare sector is also riding the (global) demographic wave of aging populations. At CVS Health drugstores, the number of prescription medicines purchased by people age 65 or older ...
- NTC and Aspen announce SAHPRA positive outcome for the fixed dose combination of levofloxacin and dexamethasone multidose eye drops
NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and Aspen Pharmacare Holdings Limited ("Aspen"), a South African-headquartered global specialty and branded pharmaceutical ...
- American Academy of Ophthalmology, Nov. 12-15
The annual meeting of the American Academy of Ophthalmology was held from Nov. 12 to 15 in New Orleans and attracted participants from around the world, including ophthalmologists, optometrists, ...
- Arctic Vision Announces First Patient Dosed in Phase III Study of ARVN001 for Treatment of Macular Edema Associated with Uveitis (UME)
First-in-class SCS Microinjection therapyFirst clinical registration study and potentially the first approved drug in China targeting macular edema associated with uveitisU.S. FDA approved for treatme ...